[1] If you are already taking B12 supplements, inform your doctor, as this may affect test interpretation
As a research compound, SLU-PP-332 has been characterized in peer-reviewed research literature examining cellular receptor binding and structure-activity relationships
$145.00 10 in stock 10 in stock This product is intended for laboratory research use only
- Any patient outcomes or progress demonstrating that the injections help alleviate symptoms and improve overall health
Studies demonstrate that NNMT inhibition "enhances fasting blood glucose levels, glucose tolerance, and insulin sensitivity" while reducing triglycerides and decreasing lipid deposition
Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes